News

The EMCDDA has launched today its first bilateral technical cooperation project with Georgia aimed at enhancing national responses to drug-related health and security threats. The EMCDDA4Georgia project (EMCDDA4GE) will focus primarily on...

In the third in its series of rapid ‘trendspotter’ studies, the EMCDDA explores the impact of COVID-19 on the drug situation and responses to it. Revisiting and reviewing findings from two studies...

Austrian Federal Minister for the European Union and Constitution Karoline Edtstadler , visits the EMCDDA today where she will meet EMCDDA Director Alexis Goosdeel . The Minister will receive a briefing on...

This content was published in the EU4MD update released on 16.04.2021. This update also presents a section on partnerships, annoucements, studies, upcoming events, and a research corner. Focus on: Methamphetamine trade in...

School-based programmes to improve mental health and well-being and reduce risks Adolescents spend a significant part of their lifetime in school and, therefore, this environment plays an important role in their social...

European Commissioner for Home Affairs Ylva Johansson paid her first visit to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) today during a day of events relating to the fight...

Do you use drugs? How many? How often? These are among the questions posed in the latest European Web Survey on Drugs , launched today by the EU drugs agency (EMCDDA). Targeted...

Today, the European Commission has proposed to control two harmful new psychoactive substances (NPS) across the European Union. The substances in question — MDMB-4en-PINACA and 4F-MDMB-BICA — are both synthetic cannabinoids, which...

The latest patterns of injecting drug use in a selection of European cities are explored today in a new study from the EMCDDA. The report presents the results of an innovative project...

Opioid substitution treatment (OST) is a key evidence-based tool used to manage opioid dependence and improve related health and social consequences. Yet increasing reports of the diversion and misuse of the controlled...

This year, the EMCDDA will embark on a new five-year Roadmap under its Strategy 2025 , kicking off with an ambitious range of activities for the period 2021–23. We enter this new...

This month, Portugal took over the rotating presidency of the Council of the EU with the motto ‘Time to deliver: a fair, green and digital recovery’. Over the next six months, Portugal...

The EMCDDA will be kicking off its 2021 programme of webinars on 3 February starting with the topic ‘ Responding to drugs and homelessness: innovative approaches in Europe ’. The link between...

Professionals, academics or experts from European Neighbourhood Policy (ENP) countries (1) will have an opportunity to participate in the European Drugs Winter and Summer Schools this year, thanks to 10 bursaries being...

Professionals, academics and experts from the Western Balkan region will have an opportunity to participate in the first European Drugs Winter School (EDWS) this year, thanks to six bursaries being offered through...

Data from hospital emergency departments show that every year in Europe thousands of individuals experience drug-related toxicity and other harms, resulting in emergency presentations to hospital ( 1 ). Supported by the...

In this first week of the new year, I would like to thank you for your continued support and wish you a very happy 2021. Ringing in the new year may have...

The emergence of new drug trafficking routes, the reduced availability of drug-related health services and the adaptation of drug treatment protocols during the COVID-19 pandemic are among the findings highlighted today in...

An increase in the open sale of cannabis products in Europe has raised questions around the possible legal and commercial status of these products. In a new report released today, Low-THC cannabis...

Dear colleagues, At the start of this year, when we embarked on our 25 years of monitoring celebrations, we knew it was going to be a special 12 months. Little did we...